Capretz & Associates

(800) 351-8588

4667 MacArthur Blvd., Suite 310
Newport Beach, CA 92660

Product Liability
individual and class
action lawsuits

Fresenius Dialysis Investigation

Capretz & Associates is investigating injury claims against Fresenius Medical Care relating to their Dialysis product known as the GranuFlo.

The GranuFlo is a product used during dialysis treatment that contains an ingredient that the body converts to bicarbonate. The GranuFlo, however, is different than rival dialysis products because it contains more of this ingredient. Unfortunately, doctors at dialysis centers in many cases apparently have not been accounting for this extra bicarbonate contribution from GranuFlo when deciding how much bicarbonate to prescribe separately. This could result in an overdose of bicarbonate, which some recent studies have suggested could lead to heart problems including cardiac arrest.

Fresenius, a German-based company, is the leading supplier of dialysis machines and disposable products, which are used by many clinics in addition to its own. In November 2011, Fresenius sent an internal memo to doctors practicing in Fresenius dialysis centers, warning them that failure to properly use the GranuFlo product appeared to be contributing to a sharp increase in the risk of patients dying suddenly from cardiac arrest. Fresenius stressed urgency for doctors to take corrective action. The problem is, however, that despite knowing of these problems with the GranuFlo, Fresenius did not immediately warn other dialysis centers that use their GranuFlo product. It was not until late March 2012 that it finally did and only after the F.D.A. received, anonymously, a copy of the internal memo and questioned Fresenius about it. Then, the F.D.A. issued an alert on May 25, 2012 that applied to all products like GranuFlo.

RenalWEB, a Web site devoted to dialysis, estimates that 125,000 patients in non-Fresenius clinics are treated with the Fresenius GranuFlo product. Dialysis centers across the nation are now checking bicarbonate levels in patients and adjusting doses if necessary.

If you or someone you know suffered a heart-related injury (i.e., heart attack, etc.) following dialysis treatment and suspect the GranuFlo product may have been used, contact us for a free legal consultation. Call us at (800) 351-8588 or email us and we will contact you.

See: NYT Article (click here); Fresenius Internal Memo (click here)

Share This Page:
Designed and Powered by NextClient

© 2014 - 2020 Capretz & Associates. All rights reserved.
Theme WebExpress™ attorney website design by

Contact Form Tab